Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 1 news story.

Research has shown that adoptive immunotherapy using natural killer cells may be beneficial in leukemia treatment.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.